Tyvin Rich
CIK 1945208 · View on SEC EDGAR ↗
First SEC filing: Sept. 7, 2022 · Latest: Sept. 7, 2022
On this page
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2022 | SHPH | S | 1,414 | $1.60 | $2,262 | 2,429 Direct | -36.79% | Disposed | -99.9% (price as of 2026-08-24) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 7, 2022 | SHPH | COMMON STOCK | 3,843 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
SHPH
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $220,226 | $43,000 | — | — | — | — | — | $263,226 |
| 2022 | $67,077 | — | $29,000 | — | — | — | — | $96,077 |
| 2021 | — | — | $29,000 | — | — | — | — | $29,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.